Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection

NCT04325633 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Stop inclusions for insufficient recruitment

Conditions

COVID-19

Interventions

DRUG: 1: Naproxen
DRUG: 2: Standard of care

Sponsor

Assistance Publique - Hôpitaux de Paris